Goldman Sachs
RXST icon

Goldman Sachs’s RxSight RXST Stock Holding History

Goldman Sachs’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.63M Buy
546,154
+50,450
+10% +$305K ﹤0.01% 4457
2026
Q1 		$3.05M Sell
495,704
-69,486
-12% -$577K ﹤0.01% 4154
2025
Q4 		$5.89M Buy
565,190
+191,643
+51% +$1.92M ﹤0.01% 3599
2025
Q3 		$3.36M Buy
373,547
+121,300
+48% +$1.06M ﹤0.01% 4018
2025
Q2 		$3.28M Sell
252,247
-58,164
-19% -$874K ﹤0.01% 3807
2025
Q1 		$7.84M Buy
310,411
+113,767
+58% +$3.38M ﹤0.01% 2921
2024
Q4 		$6.76M Buy
196,644
+64,104
+48% +$2.89M ﹤0.01% 3156
2024
Q3 		$6.55M Buy
132,540
+38,389
+41% +$1.97M ﹤0.01% 3111
2024
Q2 		$5.67M Sell
94,151
-22,839
-20% -$1.31M ﹤0.01% 3037
2024
Q1 		$6.03M Buy
116,990
+20,846
+22% +$1.02M ﹤0.01% 2921
2023
Q4 		$3.88M Buy
96,144
+32,068
+50% +$941K ﹤0.01% 3376
2023
Q3 		$1.79M Sell
64,076
-36,603
-36% -$1.09M ﹤0.01% 3849
2023
Q2 		$2.9M Buy
100,679
+23,710
+31% +$527K ﹤0.01% 3588
2023
Q1 		$1.28M Buy
+76,969
New +$1.09M ﹤0.01% 4202

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs's RXST Position: Q2 2026 in Review

Goldman Sachs increased its RxSight (RXST) stake by 10% in Q2 2026, buying an estimated $305K and bringing the position to 546,154 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #4457.

Goldman Sachs first reported a position in RXST in Q1 2023 and has held it in 14 quarters since. The position peaked at $7.84M in Q1 2025. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Goldman Sachs held 546,154 shares of RxSight worth $2.63M as of Q2 2026.
  • Goldman Sachs bought 50,450 RxSight shares in Q2 2026, an estimated $305K.
  • RxSight made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4457 holding.
  • Goldman Sachs first reported a position in RxSight in Q1 2023 and has held it in 14 quarters since.
  • Goldman Sachs's RxSight position peaked at $7.84M in Q1 2025.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.